R1	Has_value Arg1:T2 Arg2:T3	
R2	Has_temporal Arg1:T2 Arg2:T4	
R3	Has_value Arg1:T5 Arg2:T6	
R4	Has_value Arg1:T7 Arg2:T8	
R5	Has_temporal Arg1:T12 Arg2:T13	
R6	Has_negation Arg1:T12 Arg2:T14	
R7	Has_temporal Arg1:T16 Arg2:T17	
R8	Has_temporal Arg1:T19 Arg2:T18	
R9	AND Arg1:T16 Arg2:T19	
R10	Has_temporal Arg1:T15 Arg2:T20	
R11	Has_value Arg1:T21 Arg2:T22	
T1	Visit 23 38	Cachexia Clinic
T2	Condition 44 67	involuntary weight loss
T3	Value 71 100	>5% of their premorbid weight
T4	Temporal 101 129	within the previous 6 months
T5	Person 148 154	of age
T6	Value 139 147;155 163	18 years or older
T7	Measurement 175 202	Karnofsky performance score
T8	Value 206 218	60 or higher
T9	Non-query-able 224 270	Can maintain oral food intake during the study
T10	Non-query-able 275 348	Can understand the study procedures and can sign an informed consent form
T12	Drug 379 388	melatonin
T13	Temporal 362 371	currently
T14	Negation 358 361	not
T15	Drug 405 422	megestrol acetate
T16	Observation 439 450	lose weight
T17	Temporal 427 435	continue
T18	Temporal 459 475	at least 2 weeks
T19	Procedure 479 486	therapy
T20	Temporal 394 404	Are taking
T21	Measurement 499 530	calculated creatinine clearance
T22	Value 534 547	>/= 60 cc/min
